TIAA CREF Investment Management’s AnaptysBio ANAB Stock Holding History

TIAA CREF Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$3.4M	Sell	46,487 -507	-1%	-$35K	﹤0.01%	1689
2018 Q4	$3M	Sell	46,994 -1,520	-3%	-$113K	﹤0.01%	1704
2018 Q3	$4.84M	Buy	48,514 +7,670	+19%	+$636K	﹤0.01%	1588
2018 Q2	$2.9M	Sell	40,844 -33,842	-45%	-$2.84M	﹤0.01%	1968
2018 Q1	$7.77M	Sell	74,686 -28,744	-28%	-$3.24M	0.01%	1279
2017 Q4	$10.4M	Buy	103,430 +61,166	+145%	+$4.5M	0.01%	1117
2017 Q3	$1.48M	Buy	42,264 +28,420	+205%	+$767K	﹤0.01%	2324
2017 Q2	$331K	Buy	13,844 +5,663	+69%	+$142K	﹤0.01%	3017
2017 Q1	$227K	Buy	+8,181	New	+$191K	﹤0.01%	2973

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TIAA CREF Investment Management's ANAB Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its AnaptysBio (ANAB) stake by 1.1% in Q1 2019, selling an estimated $35K and leaving 46,487 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

TIAA CREF Investment Management first reported a position in ANAB in Q1 2017 and has held it in 9 quarters since. The position peaked at $10.4M in Q4 2017. 129 funds tracked by Wall St. Rank hold ANAB as of Q1 2019.

TIAA CREF Investment Management held 46,487 shares of AnaptysBio worth $3.4M as of Q1 2019.
TIAA CREF Investment Management sold 507 AnaptysBio shares in Q1 2019, an estimated $35K.
AnaptysBio made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1689 holding.
TIAA CREF Investment Management first reported a position in AnaptysBio in Q1 2017 and has held it in 9 quarters since.
TIAA CREF Investment Management's AnaptysBio position peaked at $10.4M in Q4 2017.
129 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.